Paul R. Kemp

发表

Skeletal muscle dysfunction in COPD: clinical and laboratory observations.

M. Polkey, W. Man, J. Moxham, 2009, Clinical science.

Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD

M. Polkey, W. Man, N. Hopkinson, 2011, Thorax.

miR‐424‐5p reduces ribosomal RNA and protein synthesis in muscle wasting

C. Cooper, M. Polkey, M. Griffiths, 2017, Journal of cachexia, sarcopenia and muscle.

Skeletal muscle dysfunction in COPD: clinical and laboratory observations.

M. Polkey, W. Man, J. Moxham, 2009, Clinical science.

Muscle Regeneration after Critical Illness: Are Satellite Cells the Answer?

M. Polkey, M. Griffiths, P. Kemp, 2016, American journal of respiratory and critical care medicine.

Growth differentiation factor‐15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo

Claire E. Wells, M. Polkey, W. Man, 2015, Journal of cachexia, sarcopenia and muscle.

Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD

M. Polkey, N. Hopkinson, M. Maddocks, 2014, European Respiratory Journal.

Phenotypic characteristics associated with reduced short physical performance battery score in COPD.

Jane L. Canavan, M. Polkey, W. Man, 2014, Chest.

Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (Copd); implications for stratified medicine?

M. Polkey, W. Man, R. Tal-Singer, 2013, Muscle & nerve.

MuRF-1 and Atrogin-1 Protein Expression and Quadriceps Fiber Size and Muscle Mass in Stable Patients with COPD

M. Polkey, W. Man, N. Hopkinson, 2013, COPD.

Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD

M. Polkey, N. Hopkinson, A. Schols, 2012, European Respiratory Journal.

Quadriceps wasting and physical inactivity in patients with COPD

M. Polkey, N. Hopkinson, P. Sidhu, 2012, European Respiratory Journal.

Yin Yang 1 Expression and Localisation in Quadriceps Muscle in COPD

M. Polkey, W. Man, N. Hopkinson, 2011 .

Yin Yang 1 expression and localisation in quadriceps muscle in COPD.

M. Polkey, W. Man, N. Hopkinson, 2011, Archivos de bronconeumologia.

Do Miniaturized Extracorporeal Circuits Confer Significant Clinical Benefit Without Compromising Safety? A Meta-Analysis of Randomized Controlled Trials

A. Darzi, T. Athanasiou, O. Warren, 2011, ASAIO journal.

Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.

N. Hopkinson, D. Shrikrishna, P. Kemp, 2012, Clinical science.

Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation.

M. Polkey, W. Man, J. Moxham, 2009, Clinical science.

EGF receptor (EGFR) inhibition promotes a slow-twitch oxidative, over a fast-twitch, muscle phenotype

M. Polkey, M. Moffatt, J. Mitchell, 2019, Scientific Reports.

Increased skeletal muscle-specific microRNA in the blood of patients with COPD

M. Polkey, W. Man, N. Hopkinson, 2013, Thorax.

Molecular mechanisms of intensive care unit-acquired weakness

M. Polkey, M. Griffiths, P. Kemp, 2011, European Respiratory Journal.

Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs

M. Polkey, Jen Y. Lee, T. Syburra, 2014, Thorax.

MiR-181a: a potential biomarker of acute muscle wasting following elective high-risk cardiothoracic surgery

W. Banya, M. Polkey, M. Griffiths, 2015, Critical Care.

Sustained Elevation of Circulating Growth and Differentiation Factor-15 and a Dynamic Imbalance in Mediators of Muscle Homeostasis Are Associated With the Development of Acute Muscle Wasting Following Cardiac Surgery*

M. Polkey, M. Griffiths, S. Wort, 2013, Critical care medicine.

A Randomized Controlled Trial of Angiotensin-Converting Enzyme Inhibition for Skeletal Muscle Dysfunction in COPD

M. Polkey, N. Hopkinson, J. Moxham, 2014, Chest.